KLS-13019
KLS-13019 is a potent, orally bioavailable GPR55 antagonist derived from cannabidiol (CBD) . It demonstrates neuroprotective effects, reversing chemotherapy-induced peripheral neuropathy (CIPN) in vivo and is a research tool for studying hepatic encephalopathy (HE) in preclinical models.
Product Specifications
CAS Number
1801243-39-9
Product Name Alternative
KLS 13019, KLS13019, KLS-13019
Field of Research
Pharmacology & Drug Discovery, Signal Transduction
Purity
>99.99% (May vary between batches)
Smiles
C (C) (=C) [C@H]1[C@@H] (C=C (C) CC1) C2=C (O) C=C (CC3CN (C (C) =O) C3) C=C2O
Molecular Formula
C22H29NO3
Molecular Weight
355.47
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MP1246X Each
Magic™ Membrane Protein Human SLC45A4 (Solute carrier family 45 member 4) for Antibody Discovery
Sign In for Pricing
View Details 
MBS6179180-01 0.1 mL
CDC2 (Cell Division Cycle 2, G1 to S and G2 to M, CDC28A, CDK1, DKFZp686L20222, MGC111195) (HRP)
Sign In for Pricing
View Details MBS6179180-02 5x 0.1 mL
CDC2 (Cell Division Cycle 2, G1 to S and G2 to M, CDC28A, CDK1, DKFZp686L20222, MGC111195) (HRP)
Sign In for Pricing
View Details 